M. Kraus & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.7M Buy
29,856
+176
+0.6% +$95.5K 4.28% 6
2025
Q4
$17.2M Sell
29,680
-203
-0.7% -$115K 4.8% 4
2025
Q3
$14.5M Sell
29,883
-1,194
-4% -$556K 4.05% 5
2025
Q2
$12.6M Sell
31,077
-138
-0.4% -$57.7K 3.7% 4
2025
Q1
$15.5M Buy
31,215
+2
+0% +$1.08K 4.72% 4
2024
Q4
$16.2M Sell
31,213
-53
-0.2% -$29.1K 4.87% 4
2024
Q3
$19.3M Sell
31,266
-708
-2% -$419K 5.67% 3
2024
Q2
$17.7M Sell
31,974
-307
-1% -$176K 5.42% 4
2024
Q1
$18.8M Sell
32,281
-988
-3% -$554K 5.69% 3
2023
Q4
$17.7M Buy
33,269
+138
+0.4% +$66.8K 5.75% 2
2023
Q3
$16.8M Buy
33,131
+113
+0.3% +$60.2K 5.96% 2
2023
Q2
$17.2M Sell
33,018
-266
-0.8% -$144K 5.79% 2
2023
Q1
$19.2M Sell
33,284
-408
-1% -$230K 6.77% 2
2022
Q4
$18.6M Buy
33,692
+18
+0.1% +$9.54K 6.84% 2
2022
Q3
$17.1M Sell
33,674
-89
-0.3% -$49.8K 7.15% 2
2022
Q2
$18.3M Sell
33,763
-29
-0.1% -$16K 7.1% 2
2022
Q1
$20M Sell
33,792
-1,169
-3% -$672K 6.72% 2
2021
Q4
$23.3M Sell
34,961
-351
-1% -$219K 7.43% 2
2021
Q3
$20.2M Sell
35,312
-285
-0.8% -$156K 7.19% 2
2021
Q2
$18M Sell
35,597
-218
-0.6% -$103K 6.46% 2
2021
Q1
$16.3M Buy
35,815
+15
+0% +$7.16K 6.34% 2
2020
Q4
$16.7M Sell
35,800
-179
-0.5% -$83.9K 6.96% 2
2020
Q3
$15.9M Sell
35,979
-150
-0.4% -$62K 7.5% 2
2020
Q2
$13.1M Sell
36,129
-525
-1% -$176K 6.77% 2
2020
Q1
$10.4M Sell
36,654
-162
-0.4% -$51.1K 6.31% 2
2019
Q4
$12M Sell
36,816
-170
-0.5% -$51.5K 5.97% 2
2019
Q3
$10.8M Buy
36,986
+20
+0.1% +$5.73K 5.85% 3
2019
Q2
$10.9M Sell
36,966
-294
-0.8% -$81K 6.04% 2
2019
Q1
$10.2M Sell
37,260
-545
-1% -$136K 5.96% 2
2018
Q4
$8.46M Sell
37,805
-285
-0.7% -$66.9K 5.59% 2
2018
Q3
$9.3M Sell
38,090
-185
-0.5% -$42.6K 5.39% 2
2018
Q2
$7.93M Sell
38,275
-264
-0.7% -$56K 4.98% 2
2018
Q1
$7.96M Sell
38,539
-45
-0.1% -$9.45K 5.06% 4
2017
Q4
$7.33M Sell
38,584
-630
-2% -$121K 4.44% 4
2017
Q3
$7.42M Sell
39,214
-52
-0.1% -$9.42K 4.64% 1
2017
Q2
$6.85M Sell
39,266
-85
-0.2% -$14.3K 4.33% 2
2017
Q1
$6.04M Sell
39,351
-1,074
-3% -$164K 3.97% 4
2016
Q4
$5.7M Buy
40,425
+805
+2% +$119K 3.9% 5
2016
Q3
$6.3M Sell
39,620
-1,009
-2% -$155K 4.35% 1
2016
Q2
$6M Buy
40,629
+187
+0.5% +$27.6K 4.29% 1
2016
Q1
$5.73M Sell
40,442
-1,201
-3% -$161K 4.25% 1
2015
Q4
$5.91M Buy
41,643
+445
+1% +$59.4K 4.44% 1
2015
Q3
$5.04M Sell
41,198
-1,540
-4% -$201K 4.06% 2
2015
Q2
$5.55M Sell
42,738
-505
-1% -$65.8K 4.03% 2
2015
Q1
$5.81M Buy
43,243
+270
+0.6% +$34.8K 4.17% 2
2014
Q4
$5.38M Sell
42,973
-259
-0.6% -$31.5K 3.91% 4
2014
Q3
$5.26M Sell
43,232
-285
-0.7% -$34.7K 4.03% 5
2014
Q2
$5.13M Buy
43,517
+2,020
+5% +$238K 3.9% 3
2014
Q1
$4.99M Sell
41,497
-390
-0.9% -$46.4K 4.05% 3
2013
Q4
$4.66M Buy
+41,887
New +$4.17M 3.8% 3

Other funds holding TMO

M. Kraus & Co's TMO Position: Q1 2026 in Review

M. Kraus & Co increased its Thermo Fisher Scientific (TMO) stake by 0.59% in Q1 2026, buying an estimated $95.5K and bringing the position to 29,856 shares worth $14.7M. The position accounts for 4.28% of the portfolio, ranked #6.

M. Kraus & Co first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $23.3M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • M. Kraus & Co held 29,856 shares of Thermo Fisher Scientific worth $14.7M as of Q1 2026.
  • M. Kraus & Co bought 176 Thermo Fisher Scientific shares in Q1 2026, an estimated $95.5K.
  • Thermo Fisher Scientific made up 4.28% of M. Kraus & Co's portfolio in Q1 2026, its #6 holding.
  • M. Kraus & Co first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
  • M. Kraus & Co's Thermo Fisher Scientific position peaked at $23.3M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on M. Kraus & Co's 13F filing for Q1 2026, filed 14 Apr 2026.